Integra LifeSciences extends A/R securitization facility maturity to Dec 2026

INTEGRA LIFESCIENCES HOLDINGS CORP

Amendment No. 5 extends the $150M A/R securitization facility maturity to December 15, 2026.
Facility originally entered Dec 2018; parties include Integra Receivables, ILS Sales, PNC Bank, and Bank of Nova Scotia.
Company's limited performance guaranty continues in accordance with its terms.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INTEGRA LIFESCIENCES HOLDINGS CORP amended Amendment No. 5 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty with PNC Bank, National Association (effective 2023-12-15).

Action: amendment
Agreement: credit facility
Counterparty: PNC Bank, National Association
Effective: 2023-12-15

Exact text from the filing

entered into Amendment No. 5 to Receivables Financing Agreement and Reaffirmation of Performance Guaranty, dated as of December 15, 2023

View on SEC.gov

85 material agreements filed in the last 30 days. Browse all material agreements →

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-23-000082

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.